The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 784
ISSUE 784
January 27, 1989
Issue 784
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Trimetrexate
January 27, 1989 (Issue: 784)
Trimetrexate glucuronate (Parke-Davis), an investigational drug, is now available in the USA from the National Institute of Allergy and Infectious Diseases (NIAID) for treatment of selected AIDS patients with Pneumocystis carinii pneumonia (PCP)....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.